text: DigitalMorning Reading List 07.29.09By Christine|July 29, 2009 ShareBy Christine|July 29, 2009 Share Good morning FishbowlDC! Got a blind item, interesting link, funny note, comment, birthday, anniversary or anything of the sort for Morning Reading List? Drop us a line.Happy belated birthday to NBC's Courtney Kube! What we know and what we're reading this Wednesday morning…TV | RADIO | ONLINE | WEST WING REPORTAGE | QUOTE OF THE DAY | JOBSTVCheck out cable ratings on TVNewser: Fox News Channel continued its cable news dominance in July not only beating CNN and MSNBC combined, but showing the most growth in the younger demo. In A25-54 viewers, FNC is up 48% in total day, and up 70% in primetime, compared to July '08RADIONPR's Morning Edition host Renee Montagne will file a series of special reports beginning this week from Afghanistan, focusing on the presidential election there. She'll have interviews with the two leading challengers to President Karzai- independent Abdullah Abdullah and Ashraf Ghani, as well as US special envoy to Afghanistan and Pakistan Amb. Richard Holbrooke. In a release, she says this election is "most important event in Afghanistan this year." This is Montagne's fourth time reporting from Afghanistan since 2001.ONLINEIs a deal between Microsoft and Yahoo imminent? AllThingsDigital: The online search and advertising deal between Microsoft and Yahoo has been struck and will be announced within the next 24 hours. Sources said negotiations are complete on a deal that is less sweeping than originally conceived.NEWS NOTESE&P: About 100 Associated Press employees in news, technology and business units have accepted a voluntary buyout, according to the news cooperative, which said the deadline for taking the offer was Monday.WEST WING REPORTAGECamera Hog-in-Chief? That's what Forbes is calling President Obama.QUOTE OF THE DAY"I love Sarah Palin. I mean, I love her more than anyone because, as a journalist, she is the best story ever. It's like Hollywood casting, when you have Meg Ryan playing a nuclear physicist… She is the first person to ever fuse politics with reality TV. I think she could ABSOLUTELY be the nominee. She sort of plays to people's darker impulses. And that core of the Republican Party that is left, and is very bitter, is loving her." –NYT's Maureen Dowd on Willie Geist's 5:30am MSNBC show (h/t Playbook, clearly we were not up that early).HAT TIPS: mediabistro, TVNewser, PoliticoJOBS after the jump… JOBSCheck out MediaJobsDaily. Sharehttp://adweek.it/2khUIhA copy Adweek Adweek


text:
Cape Town-based company Powertime, which allows users to buy prepaid electricity and airtime as well as pay municipality bills online, is to spin out its payment solutions division PayGenius as a separate entity this year as it looks to raise funding for the new company.
Powertime was founded in 2009, but only launched PayGenius in 2011 following the success of its mobile apps and the increasing demand for online and merchant payment solutions.
PayGenius offers innovative payment solutions: PayGenius Pro for merchants and PayGenius for consumers. The former provides merchants with a simple, convenient and cost effective way to accept credit card payments through various channels, while the latter offers South Africans a secure wallet solution to make one-click payments at any PayGenius-supported merchants.
The solution has until now been operating within Powertime, but managing director Sebastien Lacour told Disrupt Africa a separate PayGenius entity this year as they planned to raise some funding.
Any funding will be used for further expansion of a company that is already making huge progress. PayGenius has opened its multi-currency processing facility, and has expanded into Europe with an office in Paris. A new PayGenius app is also in the works.
Lacour said PayGenius had been born from the realisation that customers were willing to purchase more than just prepaid electricity, or airtime and pay their municipal bills on Powertime's website and mobile apps.
"At the same time, more and more South African merchants were willing to migrate online or to transact via mobile apps," he said. "Since we had developed all the components to securely store and process credit card information on the web and via mobile apps for Powertime, we saw an opportunity to market the payment solution as PayGenius to South African merchants and make it easier for them to migrate online."
Lacour believes the strength of PayGenius lies in its ability to deliver several payment solutions to merchants, including web, mobile and point of sale (POS), while it can also adapt to specific requirements.
"In addition, the merchant benefits from very competitive rates and a very experienced e-commerce and m-commerce partner in PayGenius," he said, with the company offering round-the-clock merchant and customer support.
The company makes money from a percentage transaction fee, with Lecour saying it processes more than US$7 million per year, with over 60 merchants operating in various industries. This is growing annually by 52 per cent.
There is plenty more for the company to achieve, according to Lacour, as it becomes an entity in its own right.
"PayGenius currently has 20,000 registered users on its platform making payment on a monthly basis," he said. "We must focus on diversifying its merchant base in order to offer customers a wider range of products and services."

subset: commoncrawl


text:
Kent Newton Salon showcases artwork from various artists in and around the Boston area that are available for purchase. Don't hesitate to request more info about them during your next salon visit.
Born in New York City, Annie earned her BFA from Smith College and her MAT in FineArts from Harvard. She has taught drawing, painting and book design in the Boston area, and has worked as a freelance illustrator and graphic designer. She has been a mixed media painter and book artist for over 30 years. Her unique handcrafted jewelry celebrates the decorative possibilities of paper, fibers, and found objects. Annie's award wınnıng work is in collections in Boston, New York, Italy, Turkey, Hungary, and Poland. She lives and works in Boston and in the Aegean coastal village of Çeşme Dalyanköy in Turkey.
June Vernon
Tom Smith


text:
ShareTweet There's good news from the Internal Revenue Service (surprise!) for people who stuff as much money as possible into their 401(k) retirement accounts; starting this year the contribution limit has been augmented to $18,000, an increase of $500. Even more good news for American workers who are 50 years of age and older is that the […]
Avoid These Mistakes That Could Put a Dent in Your 401(k)
ShareTweet Recent swings in the market have been so overwhelming that some investors are simply incredulous and completely unsure of what to do. A recent report by Aon Hewitt in October 2014 showed that consumers were favoring fixed income or bond funds over equity or stock funds as the "go to" investments for their 401(k) […]
Protecting Our Children From Identity Theft
ShareTweet One of the reasons that identity theft is now the fastest growing crime in the United States is simply this; it's a very difficult problem to solve. Even worse is the fact that, like monkeys, identity thieves go for the "lowest hanging" fruit first. In other words, they target our children because they are […]
Title Loans – An even worse way to borrow money than Payday Loans
ShareTweet Over the last couple of decades payday loans have gained prominence because of the fact that so many consumers are using them to get fast cash in a pinch and also, unfortunately, because of the fact that, when all is said and done, it's usually the consumer gets severely pinched. Now along comes away […]
How to Avoid Skyrocketing Student Debt
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 74
- Next Page »


text:
Obesity has emerged as a world-wide health problem over the past several decades. Its complications are costly on individual and societal levels. There is urgent need to identify new drug targets for ameliorating the metabolic consequences of obesity such as type 2 diabetes mellitus, hyperlipidemia, and non-alcoholic fatty liver disease. One central aspect of obesity and its attendant illnesses that requires greater understanding is how the organism can safely store the excess lipids that accumulate throughout the body in this condition. Work over the past decade has revealed that the adipose tissue is a """"""""battery of finite capacity,"""""""" and that spill-over of lipid surplus into other tissues and organs contributes to diseas burden. This application seeks to address the need for new drug targets to combat obesity and its related illnesses by responding to the NIH's """"""""Genetic Screens to Enhance Zebrafish Research (R01)"""""""" Funding Opportunity. A proposal to perform a large-scale forward genetic screen in zebrafish for lipid metabolic phenotypes, with a focus on hepatic steatosis (excess lipids in the liver) and altered adipose mass, is presented. We provide preliminary data underscoring both the feasibility of studying lipid metabolism in this model organism, and for identifying and characterizing completely novel and potentially druggable nodes of energy metabolism. We demonstrate that a wide-range of methods including molecular genetic, whole-animal physiologic, nutritional, biochemical, electrophysiologic, and microscopic techniques can be successfully applied to the study of mutants we intend to isolate in this screen in the hopes of arriving at a comprehensive view of how mutation of a single gene can give rise to complex metabolic phenotypes.
Obesity is a disease that has emerged over the past several generations in nearly all human populations, and is associated with a host of health problems. A greater understanding of how lipids are stored both in adipose tissue and elsewhere in the both may lead to new interventions to treat obesity and its related illnesses. We study how fat accumulates both in adipose tissue and elsewhere in the body by identifying and characterizing zebrafish mutants with altered lipid stores. The novel genes and pathways we identify should help address the pressing need for new treatments for obesity and its attendant illnesses.
|Karanth, Santhosh; Adams, J D; Serrano, Maria de Los Angeles et al. (2018) A Hepatocyte FOXN3-? Cell Glucagon Axis Regulates Fasting Glucose. Cell Rep 24:312-319
|Hugo, Sarah E; Schlegel, Amnon (2017) A Genetic Model to Study Increased Hexosamine Biosynthetic Flux. Endocrinology 158:2420-2426
|Hugo, Sarah E; Schlegel, Amnon (2017) A genetic screen for zebrafish mutants with hepatic steatosis identifies a locus required for larval growth. J Anat 230:407-413
|Karanth, Santhosh; Zinkhan, Erin K; Hill, Jonathon T et al. (2016) FOXN3 Regulates Hepatic Glucose Utilization. Cell Rep 15:2745-55
|Safavi-Hemami, Helena; Gajewiak, Joanna; Karanth, Santhosh et al. (2015) Specialized insulin is used for chemical warfare by fish-hunting cone snails. Proc Natl Acad Sci U S A 112:1743-8
|Schlegel, Amnon; Gut, Philipp (2015) Metabolic insights from zebrafish genetics, physiology, and chemical biology. Cell Mol Life Sci 72:2249-60
|Karanth, Santhosh; Tran, Vy My; Kuberan, Balagurunathan et al. (2013) Polyunsaturated fatty acyl-coenzyme As are inhibitors of cholesterol biosynthesis in zebrafish and mice. Dis Model Mech 6:1365-77
|Schlegel, Amnon (2012) Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology. Cell Mol Life Sci 69:3953-61
|Hugo, Sarah E; Cruz-Garcia, Lourdes; Karanth, Santhosh et al. (2012) A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev 26:282-93


text:
Beach + Jungle Splendor: The Complete Central America Package
It's time for an upgrade. If you're intimately familiar with the award-winning Mukul resort and the luxurious splendor of Nicaragua's Emerald Coast, cast your gaze southward towards Altagracia.
Welcome to our brand new Coast to Countryside Package...
Mukul has partnered with fellow Auberge Collection property, Hacienda AltaGracia, to offer a unique vacation package that literally takes you from coast to countryside.
Named the #1 resort in Central America by both Travel + Leisure and Conde Nast Traveler, Hacienda AltaGracia is the perfect slice of paradise for the beginning of your Central American adventure.
Three days of hiking, mountain biking, and magnificent horseback riding await your boots in the mountains of Perez Zeledon in southern Costa Rica. And did we mention the on-site organic farm and a series of imaginative tours that immerse you in the local culture?
When you've experienced Costa Rican perfection to the fullest, hop a private charter to Mukul for four days of world-class surfing, golfing, spa sanctuaries, and mile upon mile of pristine Nicaraguan beach.
Wake up to the song of the ocean. Spend your days golfing, hiking, lounging in a private plunge pool, or helping baby sea turtles make their way back to the waves. Enjoy a sunset cocktail from your private bohio deck. And dine beneath the stars.
Beaches to mountaintops. This is the definitive Central American experience.
This 6 night/7 day package includes three nights of luxury accommodation at each of these award-winning resorts, daily complimentary breakfast, a private chartered flight between the properties, and private ground transfers to and from the airport for a seamless entry to a perfect week.
Why settle for exploration or relaxation when you can have both? Marvel at the natural beauty in the last unexplored area of Costa Rica, before trading dusty boots for a spot by the pool and bespoke accommodations with local Nicaraguan touches.
Get in touch with our team to book your no-compromise vacation today!


text:
Dr. Gregory E. Wilding, Ph.D., is Chair and tenured Professor at the University at Buffalo (UB) Department of Biostatistics. He has been actively involved in many diverse areas of clinical and non-clinical research in academia and industry for approximately 20 years. In addition to Chair, where he oversees all educational, service, and research efforts of the department, Dr. Wilding's administrative positions also include Director of the Biostatistics, Epidemiology, and Research Design (BERD) Core of the UB Clinical and Translational Science Institute (UB CTSI). The overall objective of the BERD Core is to provide clinical and translational researchers access to a coordinated and collaborative resource for study design and statistical analysis, tailored to the individual needs of investigators. Dr. Wilding holds the additional title of Professor at Roswell Park Comprehensive Cancer Center (Roswell Park). Previous to serving as Chair at UB, Dr. Wilding held the positions of Vice Chair of the Roswell Park Comprehensive Cancer Center Department of Biostatistics and Bioinformatics and Director of the Cancer Center Support Grant (CCSG) Biostatistics Core. During his time at Roswell Park, Dr. Wilding designed well over 300 clinical trials in support of drug, diagnostic device, and medical device development, and reviewed over 1000 clinical trial protocols. He served as the sole statistician on the institute's data and safety monitoring board, which was responsible for the monitoring of all investigator-initiated trials, and served on the IRB and numerous scientific review committees. Additional appointments held by Dr. Wilding include the UB School of Nursing, Buffalo Center for Social Research, Department of Veterans Affairs, and the UB Jacobs School of Medicine and Biomedical Sciences. As an active consultant to industry, Dr. Wilding has participated in the design and analysis of studies of diagnostic and medical devices and early phase (Phase I and II) drug trials in support of applications to the FDA and non-US regulatory authorities. Additionally, Dr. Wilding has served as a DSMB member for a number of Phase II and III drug trials. Dr. Wilding's personal methodological research is in the areas of clinical trial design, permutation testing, and tests of independence. He has over 240 papers published in peer-reviewed clinical and statistical journals.
Ailawadhi S, Lee K, Klippenstein DL, Gottlieb R, Alberico RA, Wilding GE, Miller KC, Mashtare TL, Derby L, Abdelhalim AN, Chanan-Khan AA. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.Cancer 2010; 116(1):84-92
Czyrny JJ, Kaplan RE, Wilding GE, Purdy CH, Hirsh J. Electrical foot stimulation: a potential new method of deep venous thrombosis prophylaxis.Vascular 2010; 18(1):20-27
Hellenthal NJ, Ornstein D, Palou J, Peabody J, Pruthi R, Richstone L, Schanne F, Stricker H, Thomas R, Wiklund P, Wilding G, Mottrie A, Menon M, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, Kaouk J, Khan S, Kibel A, Kim H, Manoharan M, Guru KA. Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Journal of urology 2010; 184(1):87-91
May KS, Javle MM, Gibbs JF, Kuvshinoff BW, Fakih M, Russo RC, Flaherty L, Ma WW, Iyer RV, Wilding GE, Chandrasekhar R, Khushalani NI, Yang GY.Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen. International journal of radiation oncology, biology, physics2010; 76(4):1193-1198
Platek ME, Winston J, Edge SB, Nochajski TH, Russell M, Trevisan M, Millen AE, Ambrosone C, Wilding GE, Nie J, McCann SE, Bonner MR, Marian C, Tan D, Shields PG, Freudenheim JL. Alcohol consumption and breast tumor mitochondrial DNA mutations. Breast cancer research and treatment 2010;121(2):453-460
Saad RJ, Semler JR, Wilding GE, Sitrin MD, McCallum RW, Parkman HP, Kuo B, Koch KL, Rao SSC, Chey WD. Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. American journal of gastroenterology 2010;105(2):403-411
Sarosiek I, Sarosiek J, Parkman HP, Koch KL, Hasler WL, Chey WD, Kuo B, Sitrin MD, Lackner JM, Wilding GE, Semler JR, Katz LA, Selover KH, McCallum RW. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Alimentary pharmacology and therapeutics 2010; 31(2):313-322
Schneider R, Stier W, Henry T, Wilding G. Title IX compliance in NCAA Athletic departments: perceptions of senior woman administrators. Journal of human kinetics 2010; 23(1):103-113
Seixas-Mikelus SA, Adal A, Kesavadas T, Baheti A, Srimathveeravalli G, Hussain A, Chandrasekhar R, Wilding GE, Guru KA. Can image-based virtual reality help teach anatomy?. Journal of endourology 2010; 24(4):629-634
Camilleri M, Semler JR, Wilding GE, Soffer E, Parkman HP, McCallum RW, Scott SM, Gupta A, Esfandyari T, Kuo B, Hasler WL, Ringel Y, Thorne NK, Rao SSC. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterology and motility 2010; 22(8):874-882, e233
Hayn MH, Mottrie A, Ornstein D, Peabody J, Pruthi R, Palou Redorta J, Richstone L, Schanne F, Stricker H, Wiklund P, Chandrasekhar R, Wilding GE, Menon M, Manoharan M, Hussain A, Mansour AM, Andrews PE, Carpentier P, Castle E, Dasgupta P, Rimington P, Thomas R, Khan S, Kibel A, Kim H, Guru KA. The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. European urology 2010;58(2):197-202
Hayn MH, Mottrie A, Ornstein D, Peabody J, Pruthi R, Redorta JP, Richstone L, Schanne F, Stricker H, Wiklund P, Chandrasekhar R, Wilding GE, Menon M, Manoharan M, Hussain A, Mansour AM, Andrews PE, Carpentier P, Castle E, Dasgupta P, Rimington P, Thomas R, Khan S, Kibel A, Kim H, Guru KA. Reply from authors re: Urs E. Studer, Laurence Collette. Robot-assisted cystectomy: does it meet expectations?. European urology 2010; 58(2):204-206
Hellenthal NJ, Underwood W, Penetrante R, Litwin A, Zhang S, Wilding GE, Teh BT, Kim HL. Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma. Journal of urology 2010; 184(3):859-864
Kloetzer L, Hasler WL, Semler JR, Wilding GE, Parkman HP, Lackner JM, Katz LA, Sitrin M, Wo JM, Koch KL, McCallum RW, Chey WD, Kuo B. Motility of the antroduodenum in healthy and gastroparetics characterized by wireless motility capsule. Neurogastroenterology and motility 2010; 22(5):527-533, e117
Seixas-Mikelus SA, Kesavadas T, Srimathveeravalli G, Chandrasekhar R,Wilding GE, Guru KA. Face validation of a novel robotic surgical simulator.Urology 2010; 76(2):357-360
Yang GY, Fakih M, Gibbs JF, Yendamuri SS, Khushalani NI, McCloskey SA,Wilding GE, Chandrasekhar R, Iyer RV, May KS, Thomas Jr CR. Renal atrophy secondary to chemoradiotherapy of abdominal malignancies. International journal of radiation oncology, biology, physics 2010; 78(2):539-546
Kanchira K, Zakharia Y, Tan W, Liu W, Wilding G, Edge S, Tan D, Khoury T.Frozen section versus touch preparation for intraoperative detection of sentinel lymph node metastases from breast cancer: A single institution experience of 396 cases. Laboratory investigation 2010; 90(Suppl. 1):54A
Liu W, Zakharia Y, Tan W, Wilding G, Edge S, Tan D, Khoury T. Intraoperative detection of sentinel lymph node metastases from breast cancer: Does the pathologist experience, subspecialty or the surgeon experience matter?.Laboratory investigation 2010; 90(Suppl. 1):59A
Qiu J, Kulkarni S, Chandrasekhar R, Rees M, Hyde R, Wilding G, Tan D, Khoury T. Delay to formalin fixation effect on estrogen and progesterone receptors in breast cancer: A study of three different clones. Laboratory investigation 2010; 90(Suppl. 1):66A
Zhang S, Kasznica J, Chandrasekhar R, Wilding G, Khoury T. Fibroepithelial lesion with cellular stroma: Topoisomerase 2 is a helpful marker to differentiate fibroadenoma from phyllodes tumor on needle core biopsy. Laboratory investigation 2010; 90(Suppl. 1):80A
Zhang S, Zakharia Y, Tan W, Wilding G, Edge S, Liu W, Tan D, Khoury T.Breast hormonal receptors test should be repeated on excisional biopsies after negative core biopsy. Laboratory investigation 2010; 90(Suppl. 1):80A
Chadha KS, Chadha KS, Schiff M , Sitrin MD , Wilding GE , Nava H. Clinical outcomes of using a conservative approach of late esophageal stent placement in palliation of malignant dysphagia. Journal of gastrointestinal cancer 2010; 41(3):173-178
Dupont NC , Chandrasekhar R , Wilding G , Guru KA. Current trends in robot assisted surgery: a survey of gynecologic oncologists. International journal of medical robotics and computer assisted surgery 2010; 6(4):468-472
Guru K , Seixas-Mikelus SA , Hussain A , Blumenfeld AJ , Nyquist J , Chandrasekhar R, Wilding GE. Robot-assisted intracorporeal ileal conduit: Marionette technique and initial experience at Roswell Park Cancer Institute.Urology 2010; 76(4):866-871
Hayn MH , Mottrie A , Ornstein D , Peabody J , Pruthi R , Palou Redorta J , Vira M , Schanne F , Stricker H , Wiklund P , Wilding G , Menon M , Manoharan M , Kim H , Hellenthal NJ , Hussain A , Andrews PE , Carpentier P , Castle E , Dasgupta P , Davis R , Thomas R , Khan S , Kibel A , Guru KA. Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium. Urology 2010; 76(5):1111-1116
Malik NK , Wilding GE , Gibbs JF , Kuvshinoff BW , Iyer RV , Flaherty L , Ma W , May KS , Chandrasekhar R , Yang GY. Chemoradiotherapy vs. chemotherapy alone in patients with locally advanced unresectable pancreatic carcinoma: a 10-year experience. International journal of radiation oncology, biology, physics 2010; 78(3 Suppl. 1):S311-S312
May KS , Lamonica D , Nava HR , Gibbs JF , Yendamuri SS , Nwogu CE , Iyer RV , Yap JC , Warner JC , Russo RC , Malhotra HK , Flaherty L , Wilding GE , Chandrasekhar R , Khushalani NI , Yang GY , Thomas Jr CR. Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies. Journal of gastrointestinal oncology 2010;1(1):7-15
Qiu J , Kulkarni S , Chandrasekhar R , Rees M , Hyde K , Wilding G , Tan D , Khoury T. Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones. American journal of clinical pathology 2010; 134(5):813-819
Yang G , Wilding G , Kuvshinoff B , Ma W , Flaherty L , Watroba N , May KS , Chandrasekhar R , Malik N , Gibbs J. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. International journal of radiation oncology, biology, physics 2010; 78(3 Suppl. 1):S298
Yuh BE , Hussain A , Chandrasekhar R , Bienko M , Piacente P , Wilding G , Menon M , Peabody J , Guru KA. Comparative analysis of global practice patterns in urologic robot-assisted surgery. Journal of endourology 2010;24(10):1637-1644
Hellenthal NJ, Ornstein D, Palou J, Peabody J, Pruthi R, Richstone L, Schanne F, Stricker H, Thomas R, Wiklund P, Wilding G, Mottrie A, Menon M, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, Kaouk J, Khan S, Kibel A, Kim H, Manoharan M, Guru KA. Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU international 2011; 107(4):642-646
Lee HJ, Trump D, Johnson CS, Wang ES, Thompson JE, Griffiths EA, Vigil CE, Barcos M, Block A, Sait S, Ford LA, Wilding G, Wei T, Muindi J, Wetzler M.Subnormal vitamin D levels are associated with adverse outcome in newly-diagnosed similarly-treated adult acute myeloid leukemia (AML) patients. Blood2010; 116(21):Abstract #1041
Iyer RV, Johnson CS, Ramnath N, Fakih M, Muindi J, Wilding GE, Tan W, Javle MM, Fetterly GJ, Trump DL. Enhanced gemcitabine (G) exposure in combination with escalating doses of paricalcitol [19-nor-1 alpha, 25-(OH)2 D2] (P) in patients with advanced malignancies. Journal of clinical oncology 2010;28(15 Suppl.):e13031
Starostik P, Azrak S, Liang P, Wilding GE, Ademuyiwa FO, Khoury T. HER2 testing in breast cancer by universally primed quantitative multiplex PCR short fluorescent fragments (upQMPSF). Journal of clinical oncology 2010; 28(15 Suppl.):e11049
Block AW, Thompson JE, Wang ES, Starostik P, Deeb G, Sait SN, Ford L,Wilding GE, Groman AE, Wetzler M. The role of FLT3 in sole trisomy 8 acute myeloid leukemia. Journal of clinical oncology 2010; 28(15 Suppl.):6562
Salerno May K, Chandrasekhar R, Flaherty L, Russo RC, Ma W, Kuvshinoff BW, Gibbs JF, Wilding GE, Yang G. Change in renal function after chemoradiotherapy for pancreatic cancer : 2010 Gastrointestinal Cancers Symposium. Journal of clinical oncology 2010; 28(15 Suppl.):Abstract #231
Angitapalli R, Litwin AM, Kumar PRG, Nasser E, Lombardo J, Mashtare T,Wilding GE, Fakih MG. Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer. Oncology 2009; 76(5):363-368
Butt ZM, Fazili A, Tan W, Wilding GE, Filadora V, Kim HL, Mohler JL, O'Leary KA, Guru KA. Does the presence of significant risk factors affect perioperative outcomes after robot-assisted radical cystectomy?. BJU international 2009;104(7):986-990
Chadha MK, Javle MM, Kuvshinoff B, Gibbs JF, Raczyk C, Litwin A, Wilding GE, Mashtare T, Lombardo J, Iyer RV. High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors. Anticancer research 2009; 29(10):4127-4130
Chen ML, Carroll M, Kundu M, Selak MA, Prolla TA, Kujoth GC, Tan W, Wilding GE, Yu X, Shelat SG, Hochberg ML, Logan TD, Thompson JE. Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction. Blood 2009; 114(19):4045-4053
Demmy TL, Nwogu C, Solan P, Yendamuri S, Wilding G, DeLeon O. Chest tube-delivered bupivacaine improves pain and decreases opioid use after thoracoscopy. Annals of thoracic surgery 2009; 87(4):1040-1046; discussion 1046-1047
Guru KA, Menon M, Mohler JL, Wilding G, Underwood W, Glasgow M, Bienko M, Piacente P, Chandrasekhar R, Hussain A, Peabody JO. Current status of robot-assisted surgery in urology: a multi-national survey of 297 urologic surgeons. Canadian journal of urology 2009; 16(4):4736-4741
Guru KA, Perlmutter AE, Butt ZM, Piacente P, Wilding GE, Tan W, Kim HL, Mohler JL. The learning curve for robot-assisted radical cystectomy. JSLS : Journal of the Society of Laparoendoscopic Surgeons 2009; 13(4):509-514
Guru KA, Perlmutter AE, Sheldon MJ, Butt ZM, Zhang S, Tan W, Wilding G, Kim HL, Mohler JL. Apical margins after robot-assisted radical prostatectomy: does technique matter?. Journal of endourology 2009; 23(1):123-127
Harb A, Tan W, Wilding GE, Battiwalla M, Sait SNJ, Wang ES, Wetzler M.Acute myeloid leukemia and diabetes insipidus with monosomy 7. Cancer genetics and cytogenetics 2009; 190(2):97-100
Harb AJ, Wang ES, Wallace PK, Barcos M, Block AW, Sait SNJ, Ford L, Wilding GE, Tan W, Wetzler M. Treating octogenarian and nonagenarian acute myeloid leukemia patients--predictive prognostic models. Cancer 2009;115(11):2472-2481
Javle MM, Smith PF, Prey JD, Clark KR, LeVea C, Nava HR, Schiff MD, Vinjamaram S, O'Malley L, Wilding GE, Nwogu CE, Yang G, Pendyala L.Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis. Cancer investigation 2009;27(2):193-200
Kabingu E, Oseroff AR, Wilding GE, Gollnick SO. Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clinical cancer research 2009; 15(13):4460-4466
Khoury T, Arshad A, Bogner P, Ramnath N, Zhang S, Chandrasekhar R,Wilding G, Alrawi S, Tan D. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms. Chest 2009; 136(1):220-228
Khoury T, Sait S, Hwang H, Chandrasekhar R, Wilding G, Tan D, Kulkarni S.Delay to formalin fixation effect on breast biomarkers. Modern pathology 2009;22(11):1457-1467
Kim HL, Shah SK, Tan W, Shikanov SA, Zorn KC, Shalhav AL, Wilding GE.Estimation and prediction of renal function in patients with renal tumor. Journal of urology 2009; 181(6):2451-2460; discussion 2460-2461
Puthillath A, Mashtare Jr T, Wilding G, Khushalani N, Steinbrenner L, Ross ME, Romano K, Wisniewski M, Fakih MG. A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer. Critical reviews in oncology/hematology 2009; 71(3):242-248
Sahai RK, Nwogu CE, Yendamuri S, Tan W, Wilding GE, Demmy TL. Is thoracoscopic pneumonectomy safe?. Annals of thoracic surgery 2009;88(4):1086-1092
Shah SK, Trump DL, Sartor O, Tan W, Wilding GE, Mohler JL. Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy. Journal of urology 2009; 181(2):621-626
Singh SS, Wilding GE, Chandrasekhar R, Ivanova A, Maygarden SJ, Pop EA, Jeyaraj DA, Ford III OH, Mehedint DC, Mohler JL. Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis. Prostate2009; 69(15):1603-1610
Wernberg JA, Yap J, Murekeyisoni C, Mashtare T, Wilding GE, Kulkarni SA.Multiple primary tumors in men with breast cancer diagnoses: a SEER database review. Journal of surgical oncology 2009; 99(1):16-19
Yuh B, Butt Z, Fazili A, Piacente P, Tan W, Wilding G, Mohler J, Guru K. Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysis. BJU international 2009; 103(6):800-804
Yuh BE, Ciccone J, Chandrasekhar R, Butt ZM, Wilding GE, Kim HL, Mohler JL, Guru KA. Impact of previous abdominal surgery on robot-assisted radical cystectomy. JSLS : Journal of the Society of Laparoendoscopic Surgeons2009; 13(3):398-405
Vaidyanathan G, Groman A, Wilding G, Fakih MG. Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer. Oncology 2010; 79(1-2):67-71
Tjaden K, Sussman JE, Liu G, Wilding G. Long-term average spectral (LTAS) measures of dysarthria and their relationship to perceived severity. Journal of medical speech-language pathology 2010; 18(4):125-132
Bernstein JM, Allen C, Rich G, Dryja D, Bina P, Reiser R, Ballow M, Wilding GE. Further observations on the role of Staphylococcus aureus exotoxins and IgE in the pathogenesis of nasal polyposis. Laryngoscope 2011; 121(3):647-655
Fakih M, Muindi J, McMahon J, Wilding G, Romano K, Wisniewski M, Egorin M.A phase II study of two dose levels of vorinostat (V) in combination with fluorouracil (5-FU) and leucovorin (LV) in fluoropyrimidine-refractory colorectal cancer (CRC) patients (PTS). Annals of oncology 2010; 21(Suppl. 8):200
Khoury T, Chandrasekhar R, Wilding G, Tan D, Cheney RT. Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma. International journal of experimental pathology 2011; 92(2):87-96
Khoury T, Zakharia Y, Tan W, Kulkarni S, Liu W, Zhang S, Wilding GE, Edge S.Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy. Breast journal 2011; 17(2):180-186
Monhollen L, Kumar P, Chandrasekhar R, Wilding G, Khoury T. The histopathologic findings of magnetic resonance imaging enhancement of breast lesions with histologically mass-negative lesion: A single institution experience. Laboratory investigation 2011; 91(Suppl. 1):219
Monhollen L, Morrison C, Ademuyiwa F, Chanddrasekhar R, Wilding G, Khoury T. Invasive pleomorphic lobular carcinoma: A clinicopathologic and immunohistochemistry study of 40 cases. Laboratory investigation 2011;91(Suppl. 1):217
Monhollen L, Morrison C, Ademuyiwa F, Chandrasekhar R, Wilding G, Khoury T. Pleomorphic lobular carcinoma: Immunohistochemistry study of 27 cases.Laboratory investigation 2011; 91(Suppl. 1):218
Seixas-Mikelus SA , Stegemann AP , Kesavadas T , Srimathveeravalli G , Sathyaseelan G , Chandrasekhar R , Wilding GE , Peabody JO , Guru KA.Content validation of a novel robotic surgical simulator. BJU international 2011;107(7):1130-1135
Tjaden K, Wilding G. Effects of speaking task on intelligibility in Parkinson's disease. Clinical linguistics and phonetics 2011; 25(2):155-168
Turner BM, Kumar P, Chandraseekhar R, Wilding G, Khoury T. Unnecessary subsequent surgery might be avoided for a diagnosis of atypical ductal hyperplasia on a core needle biopsy by evaluating histologic features: A study of 71 cases. Laboratory investigation 2011; 91(Suppl. 1):269
Ghadersohi A, Sharma S, Zhang S, Azrak RG, Wilding GE, Manjili MH, Li F.Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer. Prostate 2011; 71(11):1178-1188
Kesavadas T, Stegemann A, Sathyaseelan G, Chowriappa A, Srimathveeravalli G, Seixas-Mikelus S, Chandrasekhar R, Wilding G, Guru K. Validation of Robotic Surgery Simulator (RoSS). Studies in health technology and informatics 2011; 163:274-276
Monhollen L, Morrison C, Ademuyiwa F, Chandrasekhar R, Wilding G, Khoury T. Pleomorphic Lobular Carcinoma: Immunohistochemistry Study of 27 Cases.Modern pathology 2011; 24(Suppl. 1):218
Noor SJ, Wang ES, Thompson JE, Block AW, Sait SN, Barcos M, Ford LA,Wilding GE, Tan W, Wetzler M. Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 cases. Leukemia research2011; 35(5):608-613
Sher T, Lee K, Iancu D, Masood A, Jamshed S, Lawrence W, Soniwala S, Sood R, Hong F, Hernandez-Ilizaliturri FJ, Czuczman MS, Wilding G, Tan W, Wood M, Manfredi D, Miller KC, Ailawadhi S, Chanan-Khan A. A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients. British journal of haematology 2011; 154(1):104-110
Meguerditchian AN, Asubonteng K, Young C, Lema B, Wilding G, Kane JM 3rd.Thick primary melanoma has a heterogeneous tumor biology: an institutional series. World journal of surgical oncology 2011; 9:40
Buitrago S, Martin TE, Tetens-Woodring J, Belicha-Villanueva A, Wilding GE.Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice. Journal of the American Association for Laboratory Animal Science : JAALAS 2008; 47(1):11-17
Butt ZM, Perlmutter AE, Piacente PM, Wilding G, Tan W, Kim HL, Mohler JL, Guru KA. Impact of body mass index on robot-assisted radical cystectomy.JSLS : Journal of the Society of Laparoendoscopic Surgeons 2008; 12(3):241-245
Gottlieb RH, Litwin A, Gupta B, Taylor J, Raczyk C, Mashtare T, Wilding G, Fakih M. Qualitative radiology assessment of tumor response: does it measure up? . Clinical imaging 2008; 32(2):136-140
Guru KA, Sternberg K, Wilding GE, Tan W, Butt ZM, Mohler JL, Kim HL. The lymph node yield during robot-assisted radical cystectomy. BJU international2008; 102(2):231-234; discussion 234
Javle M, Pande A, Iyer R, Yang G, LeVea C, Wilding G, Black J, Nava H, Nwogu C. Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response. American journal of clinical oncology 2008; 31(4):329-334
Jenkins LC, Nogueira M, Wilding GE, Tan W, Kim HL, Mohler JL, Guru KA.Median lobe in robot-assisted radical prostatectomy: evaluation and management. Urology 2008; 71(5):810-813
Pande R, Sunga A, Levea C, Wilding GE, Bshara W, Reid M, Fakih MG.Significance of signet-ring cells in patients with colorectal cancer. Diseases of the colon and rectum 2008; 51(1):50-55
Patel M, Ailawadhi S, Hernandez-Ilizaliturri F, Wilding GE. Vascular endothelial growth factor polymorphisms in early-stage non-small-cell lung cancer. Journal of clinical oncology 2008; 26(19):3289-3290; author reply 3290
Shivakumar R, Tan W, Wilding GE, Wang ES, Wetzler M. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases. Annals of oncology 2008; 19(9):1634-1638
Yuh B, Padalino J, Butt ZM, Tan W, Wilding GE, Kim HL, Mohler JL, Guru KA.Impact of tumour volume on surgical and pathological outcomes after robot-assisted radical cystectomy. BJU international 2008; 102(7):840-843
Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel.Annals of surgical oncology 2007; 14(8):2263-2269
Bir A, Tan W, Wilding GE, Lombardo J, Fakih MG. 5-Fluorouracil, Leucovorin and Oxaliplatin Plus Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer: a Single-Institute Study. Oncology 2007; 72(1-2):4-9
Guru KA, Wilding GE, Piacente P, Thompson J, Deng W, Kim HL, Mohler J, O'Leary K. Robot-assisted radical cystectomy versus open radical cystectomy: assessment of postoperative pain. Canadian journal of urology 2007;14(6):3753-3756
Puthillath A, Dunn KB, Rajput A, Smith J, Yang G, Wilding GE, Tan W, Gupta B, Fakih MG. Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer. Clinical colorectal cancer 2007; 6(10):710-715
Gage EA, Yasko J, Wilding GE, Panagakis C, Kelly M, Groman A, Ch'ng J, Zevon MA, Pailler M, Gruber M. Structuring survivorship care: discipline-specific clinician perspectives. Journal of cancer survivorship 2011; 5(3):217-225
Kuo B, Maneerattanaporn M, Lee AA, Baker JR, Wiener SM, Chey WD, Wilding GE, Hasler WL. Generalized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipation. Digestive diseases and sciences 2011; 56(10):2928-2938
Nava HR, Allamaneni SS, Dougherty TJ, Cooper MT, Tan W, Wilding G, Henderson BW. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with barrett's esophagus. Lasers in surgery and medicine 2011; 43(7):705-712
Ryan RM, Wilding GE, Wynn RJ, Welliver RC, Holm BA, Leach CL. Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator-associated pneumonia in a neonatal intensive care unit. Journal of perinatology 2011; 31(9):607-614
Tornatore KM, Forrest A, Zack J, Wilding GE, Attwood K, Danison RT, Gundroo AC, Leca N, Difrancesco R, Dole K, Sudchada P, Venuto RC.Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and caucasian renal transplant recipients. Journal of clinical pharmacology 2011; 51(8):1213-1222
Al-Agha OM, Liu W, Chandrasekhar R, Wilding G, Tan D, Alrawi S, Khoury T.CD138 (Syndecan-1) in thymic tumors: correlation with various World Health Organization types and clinical outcome. International journal of clinical and experimental pathology 2010; 3(3):280-287
Harrison MR, Hahn NM, Pili R, Oh WK, Hammers H, Sweeney C, Kim K, Perlman S, Arnott J, Sidor C, Wilding G, Liu G. A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal(R) dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).Investigational new drugs 2011; 29(6):1465-1474
Fauci JM, Schneider KE, Frederick PJ, Wilding G, Consiglio J, Sutton AL, Kilgore LC, Barnes MN. Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma.International journal of gynecological cancer 2011; 21(5):806-810
Vigil CE, Tan W, Wilding GE, Garcia-Manero G, Wang ES, Wetzler M, List AF.Comparison of outcome in erythroleukemia patients treated with standard chemotherapy regimens or hypomethylating agents : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):6630
Agrawal S, McCarron EC, Wilding GE, Gibbs JF, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel.Annals of surgical oncology 2007; 14(2 Suppl.):59-60
Ahluwalia MS, Klein K, Kuvshinoff BW, Hernandez-Ilizaliturri FJ, Wilding G, Smith JL, Battiwalla M. Improving Compliance with Guidelines for Venous Thromboembolism (VTE) Prophylaxis Significantly Reduces VTE Events. Blood2008; 112(11):466
Ailawadhi S, Derby L, Mashtare TL, Miller KC, Wilding G, Padmanabhan S, Gottlieb R, Alberico RA, Klippenstein DL, Abdelhalim AN, Chanan-Khan AA.Determining the extent of disease with magnetic resonance imaging of the bone marrow (BM-MRI) in patients with multiple myeloma (MM). Blood 2007;110(11 Part 1):Abstract #1483
Ailawadhi S, Derby L, Miller KC, Mashtare TL, Wilding G, Padmanabhan S, Gottlieb R, Alberico RA, Klippenstein DL, Abdelhalim AN, Chanan-Khan AA.Improved sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in quantifying the extent of bone marrow involvement in patients with Multiple Myeloma (MM). Blood 2007; 110(11 Part 2):267B (Abstract #4776)
Ailawadhi S, Elefante A, O'Connor TL, Wilding GE, Tan W, Kossoff E, McCuthcheon S, Miller KC, Sher T, Patel M, Lee K, Chanan-Khan AA. High Body Surface Area (BSA) Is An Independent Risk Factor for Developing Bisphosphonate-Induced Osteonecrosis of the Jaw (ONJ). Blood 2008;112(11):962-963
Ailawadhi S, Mashtare TL, Coignet MV, Depaolo DM, Miller KC, Wilding G, Chanan-Khan AA. Renal dysfunction does not affect clinical response in multiple myeloma (MM) patients treated with bortezomib-based regimens.Blood 2007; 110(11 Part 1):Abstract #1477
Ailawadhi S, Sher T, Patel M, Derby L, Mashtare T, Wilding GE, Miller K, Mohr A, Lee K, Chanan-Khan AA. International Staging System (ISS) Is Superior to Durie-Salmon (DS) Staging in Predicting Overall Mortality in Multiple Myeloma (MM). Blood 2008; 112(11):948
Azrak S, Ping L, Starostik P, Wilding G, Khoury T. Universally-Primed Quantitative Multiplex PCR Short Fluorescent Fragments (upQMPSF): A New Detection Method for HER2 Amplification in Breast Cancer. Laboratory investigation 2009; 89(Suppl. 1):28A (Abstract #113)
Chadha M, Chadha K, Lombardo J, Mashtare T, Wilding G, Gibbs J, Kuvshinoff B, Litwin A, Raczyk C, Javle M, Iyer R. Dose Escalation of Octreotide Acetate for Management of Gastro-entero-pancreatic Neuroendocrine Tumors. American journal of gastroenterology 2009;104(Suppl. 3):S103 (Abstract #268)
DePaolo D, Miller KC, Whitworth A, Mohr A, Mashtare TL, Wilding G, Ailawadhi S, Padmanabhan S, Chanan-Khan AA. Oral acyclovir is an effective in decreasing the incidence of bortezomib associated herpes zoster in patients with multiple myeloma. Blood 2007; 110(11 Part 2):286B (Abstract #4844)
Ghadersohi A, Bogner PN, Fayazi Z, Demmy TL, Reid M, Wilding G, Reska N, Slocum H, Groth J, Azrak RG, Rustum YM, Li F. Downregulation of PDEF expression in lung carcinoma is associated with up regulation of survivin and malignant potential. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:797
Ghadersohi A, Sharma S, Zhang S, Fayazi Z, Azrak RG, Rustum YM, Mohler J, Groth J, Wilding G, Slocum H, Li F. The prognostic significance of prostate derived Ets transcription factor expression in prostate cancer patients.Proceedings of the American Association for Cancer Research Annual Meeting2007; 48:400-401
Harrison MR, Pili R, Logan T, Wilding G, Eickhoff J, Sidor C, Staab M, Arnott J, Liu G. Phase II study of 2-methoxyestradiol NanoCrystal dispersion (2ME2) alone and in combination with sunitinib (SU) in patients with metastatic renal cell carcinoma (mRCC) progressing on SU. Journal of clinical oncology 2009;27(15 Suppl.):Abstract #e16116
Higgs DE, Bogner PN, Hicks DG, Starostik P, Wilding GE, Mashtare TL, Merzianu M. Oligo- and polyclonal B cell response to lung carcinoma is common. Laboratory investigation 2007; 87(Suppl. 1):1486
Khoury T, Sait S, Wilding G, Chandrasekhar R, Daoud N, Kulkarni S. Delayed Formalin Fixation Effect on Breast Biomarkers. Laboratory investigation 2009;89(Suppl. 1):50A (Abstract #215)
Khoury T, Wilding G, Chandrasekhar R, Alrawi S, Tan D. A Panel of Immunohistochemistry To Differentiate Various WHO Types of Thymic Neoplasms. Laboratory investigation 2009; 89(Suppl. 1):355A (Abstract #1609)
May KS, Fakih M, Khushalani N, Chandrasekhar R, Wilding G, Park L, Flaherty L, Russo R, Iyer R, Yang G. Renal Function following Abdominal Chemoradiotherapy for Gastrointestinal Malignancies in Elderly Patients.International journal of radiation oncology, biology, physics 2009; 75(3 Suppl.):S268-S269
May KSS, Yang GY, Iyer RV, Chandrasekhar R, Wilding G, Khushalani NI, Yendamuri SS, Gibbs JF, Fakih M. Renal atrophy secondary to chemoradiation treatment of abdominal malignancies. Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #e15532
McCloskey SA, Yang GY, Flaherty L, Chandrasekhar R, Wilding G, May KS, Hackett R, Thompson GM, Gomez JA, Thomas CR. Renal atrophy secondary to radiation treatment of abdominal malignancies. International journal of radiation oncology, biology, physics 2008; 72(1 Suppl.):S84
Meguerditchian A, Asubonteng K, Young CJ, Lema B, Wilding G, Kane JM.Thick primary melanomas: A heterogeneous tumor biology? . Annals of surgical oncology 2008; 15(Suppl. 2):98
Noor S, Tan W, Wilding G, Ford LA, Barcos M, Sait SNJ, Block AW, Thompson JE, Wang ES, Wetzler M. Myeloid Blastic Transformation of Myeloproliferative Neoplasms - A Review of 113 Cases. Blood 2009; 114(22):1210
Ong ES, Schlieman MG, Tan W, Wilding GE, Kane JM. Merkel cell carcinoma: The role of sentinel lymph node biopsy and adjuvant radiation. Annals of surgical oncology 2008; 15(Suppl. 2):99
Ong ES, Wernberg J, Alassas MM, Mashtare T, Wilding G, Rajput A, Fakih M, Dunn KB. Trends in surgical management of stage IV colorectal cancer 1988-2004. Annals of surgical oncology 2008; 15(Suppl. 2):87
Patel M, Sher T, Ailawadhi S, Mashtare T, Tan W, Soni P, Wilding G, Miller KC, Mohr A, Lee KP, Chanan-Khan AA. Novel Agents Overcome the Adverse Prognosis Imparted by Compromised Renal Function in Patients with Multiple Myeloma. Blood 2008; 112(11):942
Sher T, Miller KC, Ailawadhi S, Manfredi D, Wood M, Tan W, Wilding G, Liu H, Czuczman MS, Hernandez F, Hong F, Sood R, Soniwalla S, Lawrence W, ipd_10, Lee KP, Chanan-Khan A. Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT), An Effective Steroid Independent Regimen for Previously Untreated Multiple Myeloma Patients: Final Result of a Phase II Study. Blood 2009; 114(22):256
Shivakumar R, Tan W, Wilding G, Wang ES, Wetzler M. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia - Review of 101 cases. Blood 2007; 110(11 Part 2):154B (Abstract #4345)
Smiley SL, Hahn T, Tan W, Wilding G, Battiwalla M, McCarthy PL. BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (>= 60 years) Patients. Blood 2008; 112(11):759
Yang G, Khushalani NI, Chandrasekhar R, Wilding GE, McCloskey SA, Flaherty L, Yap JC, Gibbs JF, Fakih MG, May KS. Renal Atrophy Secondary to Abdominal Chemoradiotherapy: Receiver Operating Characteristic (ROC) Analysis. International journal of radiation oncology, biology, physics 2009;75(3 Suppl.):S262-S263
Yang GY, Flaherty L, Wagner TD, Yap JC, Chandrasekhar R, Wilding G, Khushalani NI, Iyer RV, Lamonica D, Thomas CR. Subclinical impairment of renal function following abdominal radiotherapy: An analysis using specific scintigraphic and biochemical endpoints. International journal of radiation oncology, biology, physics 2008; 72(1 Suppl.):S478-S479
Yang GY, Parikh KS, Flaherty L, Chandrasekhar R, Wilding G, Russo RC, Fakih M, Kuvshinoff BW, Gibbs JF, Javle M. Renal function after radiotherapy to the abdomen. International journal of radiation oncology, biology, physics2008; 72(1 Suppl.):S275
Zeidan A, Tan W, Wilding G, Ford L, Hahn T, Smiley S, Battiwalla M, McCarthy PL, Wang ES, Wetzler M. Gemtuzumab Ozogamicin (GO) and Continuous Infusion Cytarabine (ARA-C) for Relapsed/Refractory Acute Myeloid Leukemia (AML) Prior to Allogeneic Stem Cell Transplantation (SCT). Blood 2008;112(11):350-351
Lee HJ, Wright KM, Kandeel E, Tan W, Wilding GE, Ford LA, Sait SN, Block AMW, Barcos MP, McCarthy PL, Vigil CE, Griffiths EA, Thompson JE, Wang ES, Wallace PK, Wetzler M. The role of minimal residual disease (MRD) by flow cytometry (FC) in predicting outcome in similarly treated acute lymphoblastic leukemia (ALL) patients : ASCO Meeting Abstracts Part 1.Journal of clinical oncology 2011; 29(15 Suppl.):6592
Chanan-Khan AA, Chitta K, Ersing N, Paulus A, Masood A, Sher T, Swaika A, Wallace PK, Mashtare TL Jr, Wilding G, Lee K, Czuczman MS, Borrello I, Bangia N. Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response. British journal of haematology 2011; 155(4):457-467
Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, Gill S, Frustino J, Wilding G, Loree T, Popat S, Sullivan M. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral oncology 2011; 47(11):1048-1054
Platek ME, Reid ME, Wilding GE, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head and neck 2011; 33(11):1561-1568
Fakih M, Groman A, McMahon J, Romano K, Wisniewski M, Wilding G, Fetterly G, Muindi J. A Phase II Randomized Study of Two Doses of Vorinostat in Combination With 5-FU/LV in Patients With Refractory Colorectal Cancer (CRC). European journal of cancer (Oxford, England : 1990) 2011; 47(Suppl. 1):S423
Shan G, Ma C, Hutson AD, Wilding GE. An efficient and exact approach for detecting trends with binary endpoints. Statistics in medicine 2012; 31(2):155-164
Heimburg-Molinaro J, Almogren A, Morey S, Glinskii OV, Roy R, Wilding GE, Cheng RP, Glinsky VV, Rittenhouse-Olson K. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen. Neoplasia (New York, N.Y.) 2009; 11(8):780-792
Takita H, Shin KH, Soh AY, Yi WS, Wilding G. Induction therapy of loco-regional non-small-cell lung cancer with reliable response and low toxicity (low dose radiotherapy sensitizes tumor to subsequent chemotherapy?). Lung cancer (Amsterdam, Netherlands) 2009; 63(3):387-392
Tian L, Wilding GE. Confidence interval estimation of a common correlation coefficient. Computational statistics and data analysis 2008; 52(10):4872-4877
Tjaden K, Wilding G. Speech and pause characteristics associated with voluntary rate reduction in Parkinson's disease and Multiple Sclerosis. Journal of communication disorders 2011; 44(6):655-665
Tjaden K, Wilding G. The impact of rate reduction and increased loudness on fundamental frequency characteristics in dysarthria. Folia phoniatrica et logopaedica 2011; 63(4):178-186
Wilding GE, Mudholkar GS. Empirical approximations for Hoeffding's test of bivariate independence using two Weibull extensions. Statistical methodology2008; 5(2):160-170
Wilding GE, Mudholkar GS. Some modifications of the Z -tests of normality and their isotones. Statistical methodology 2008; 5(5):397-409
Wilding GE, Mudholkar GS. A gamma goodness-of-fit test based on characteristic independence of the mean and coefficient of variation. Journal of statistical planning and inference 2008; 138(12):3813-3821
Wilding GE, Mudholkar GS, Kollia GD. Two sets of isotones for comparing tests of exponentiality. Journal of statistical planning and inference 2007;137(11):3815-3825
Liu H, Hahn T, Wilding G, Groman A, Bambach B, Higman M, Ross M, Chen GL, McCarthy PL Jr. Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). Blood 2011; 118(21):4570
Bruce JY, Eickhoff J, Pili R, Logan T, Carducci M, Arnott J, Treston A, Wilding G, Liu G. A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate. Investigational new drugs 2012; 30(2):794-802
Fakih MG, Groman A, McMahon J, Wilding G, Muindi JR. A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer. Cancer chemotherapy and pharmacology 2012;69(3):743-751
Fora A, Patta A, Attwood K, Wilding G, Fakih M. Intensive radiographic and biomarker surveillance in stage II and III colorectal cancer. Oncology 2012;82(1):41-47
Hutson AD, Wilding GE. An examination of the relative impact of type I and type II error rates in phase II drug screening trial queues. Pharmaceutical statistics 2012; 11(2):157-162
Wilding GE, Shan G, Hutson AD. Exact two-stage designs for phase II activity trials with rank-based endpoints. Contemporary clinical trials 2012; 33(2):332-341
Ailawadhi S, Miecznikowski J, Gaile DP, Wang D, Sher T, Mulligan G, Bryant B,Wilding GE, Mashtare T, Stein L, Masood A, Neuwirth R, Lee KP, Chanan-Khan A. Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma.Leukemia and lymphoma 2012; 53(6):1174-1182
Bernstein JM, Lehman H, Lis M, Sands A, Wilding GE, Shultz L, Bankert R, Bobek L. Humanized mouse model used to monitor MUC gene expression in nasal polyps and to preclinically evaluate the efficacy of montelukast in reducing mucus production. Annals of otology, rhinology, and laryngology2012; 121(5):307-316
Hutson AD, Wilding GE. Maintaining the exchangeability assumption for a two-group permutation test in the non-randomized setting. Journal of applied statistics 2012; 39(7):1593-1603
Nurkin S, Nava HR, Yendamuri S, Levea CM, Nwogu C, Wilding G, Khushalani N. Outcomes of Endoscopic Resection for High Grade Dysplasia and Esophageal Cancer. Gastrointestinal endoscopy 2012; 75(4 Suppl.):473
Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.Molecular endocrinology (Baltimore, Md.) 2012; 26(5):716-735
Stegemann A, Rehman S, Brewer K, Kesavadas T, Hussain A, Chandrasekhar R, Wilding GE, Guru KA. Short-term Patient-reported Quality of Life After Robot-assisted Radical Cystectomy Using the Convalescence and Recovery Evaluation. Urology 2012; 79(6):1274-1280
Tornatore K, Minderman H, McQuire O, O'Louglin K, Shan G, Wilding G, Venuto R. Nuclear Localization of Nuclear Factor of Activated T-Cells as a Pharmacodynamic Marker of Tacrolimus Immunosuppression in Renal Transplant Recipients. American journal of transplantation 2012; 12(Suppl. 3):285
Fora AA, McMahon JA, Wilding G, Groman AE, Ma WW, Romano KS, Fakih M.A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS-wild type tumors who progressed on prior standard dose cetuximab and irinotecan. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #3582
Ailawadhi S, Mashtare TL, Coignet MV, DePaolo DM, Miller KC, Padmanabhan S, Wilding G, Starostik P, Chanan-Khan AA. bcl-2 translocation [t(14;18) (q32;q21)] does not correlate with poor clinical outcome in multiple myeloma patients treated with bortezomib. Blood 2007; 110(11 Part 1):Abstract #1498
Hahn T, Jensen S, Lopez F, Zevon M, Tan W, Wilding G, Paddon C, White J, Thomas J, Battiwalla M, Smiley SL, McCarthy PL. Psychosocial Factors and Overall Survival After Autologous and Allogeneic BMT. Biology of blood and marrow transplantation 2009; 15(2 Suppl. 2):147
Hahn T, Smiley SL, Tan W, Wilding G, Thomas J, Fassl K, Wright C, Battiwalla M, McCarthy PL. Physical Performance Factors and Overall Survival After Autologous and Allogeneic BMT. Biology of blood and marrow transplantation2009; 15(2 Suppl. 2):97
Padmanabhan S, Block AW, Wallace P, Tan W, Nowak N, Varadarajan P, Barcos M, Hernandez F, Ketepalli S, Wilding G, Czuczman M, Chanan-Khan A.Concomitant z score and ZAP 70 along with ATM deletion identifies patients with poor survival from the RPCI Chronic Lymphocytic Leukemia Series: A correlation of treatment and survival of B-CLL patients with prognostic variables such as fish, ZAP70 expression, CGH. Haematologica 2008;93(Suppl. 1):416 (Abstract #1053)
Sher T, Miller K, Patel M, Whitworth A, Musial L, Lawrence D, Padmanabhan S, Ailawadhi S, Wilding G, DePaolo D, Bangia N, Czuczman MS, Wallace PK, Lee KP, Khan AC. Lenalidomide associated tumor flare reaction correlates with clinical response in patients with relapsed or refractory B-cell chronic lymphocytic leukemia. Haematologica 2009; 94(Suppl. 2):0928
Tornatore KM, DiFrancesco R, Sudchada P, Gundroo A, Minderman H, O'Loughlin K, Wilding G, Danison R, Venuto RC. Assessment of P-glycoprotein Function in Peripheral Mononuclear Cells in African American and Caucasian Renal Transplant Recipients During Chronic Cyclosporine Therapy. Clinical pharmacology and therapeutics 2009; 85(Suppl. 1):S75
Antonarakis ES, Heath EI, Posadas EM, Harrison MR, Bruce JY, Yu EY, Cho SY, Wilding GE, Fetterly GJ, Hangauer DG, Kwan M-F, Dyster LM, Carducci MA, Prostate Cancer Clinical Trials Consortium (PCCTC). A phase II study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer (CRPC): A PCCTC trial : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #4654
Fora AA, Patta AM, Attwood K, Wilding GE, Fakih M. Intensive radiographic and CEA screening and salvage resection in patients with stage II and III colorectal cancer : 2012 Gastrointestinal Cancers Symposium. Journal of clinical oncology 2012; 30(4 Suppl.):Abstract #405
O'Malley RL, Hayn MH, Wilding G, Schwaab T. Population-based analysis of cancer control of partial nephrectomy for high-risk localized renal cell carcinoma : 2012 Genitourinary Cancers Symposium. Journal of clinical oncology 2012; 30(5 Suppl.):Abstract #385
Poch MA, Mehedint D, Curtis A, Attwood K, Wilding GE, Ondracek RP, Underwood W, Schwaab T, Guru K, Mohler J, Heemers H. Association of calcium channel blocker use with prostate cancer aggressiveness, progression-free survival, and overall survival : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e15204
Poch MA, Stegemann A, Chandrasekhar R, Hayn M, Wilding G, Guru KA. Does body mass index impact the performance of robot-assisted intracorporeal ileal conduit?. Journal of endourology 2012; 26(7):857-860
O'Connor TL, Edge SB, Kossoff EB, Groman A, Wilding GE, Ademuyiwa FO, Levine EG, Watroba N, Ngamphaiboon N. Factors affecting the delivery of adjuvant/neoadjuvant chemotherapy in older women with breast cancer.Journal of geriatric oncology 2012; 3(4):320-328
Wang ES, Zeidan A, Tan W, Wilding GE, Ford LA, Wallace PK, Hahn TE, Battiwalla M, McCarthy PL, Wetzler M. Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia. Leukemia and lymphoma 2012;53(10):2085-2088


text:
Experience integration through whole-body movement. Learn the 26 Brain Gym activities, Edu-K's Five Steps to Easy Learning, and Dennison Laterality Repatterning as you discover an exciting tool for reaching personal goals. What this course conveys can be applied by students, teachers, parents, artists, athletes, healthcare workers, business professionals . . . you name it! Accepted by NBCOT.
The deposit for this course is $100, and the full tuition is $450.
Date/ Location:
Deposit/ Full:


text:
When my sister gave me Tina Fey's book "Bossypants" a couple of years ago for my birthday, all in jest of course, it reminded me of the forces that shape us and how difficult it is to change a habit. As the eldest, I took life far too seriously. To this day, my sisters frequently kid me about my relentless messaging to them. In my view, they always seemed to be fooling around, slacking off. "Work hard", I told them, so they could take care of themselves as adults, not depend on a man for their well-being.
Not surprisingly I have made a career out of the value (or not) of working hard. It's much more nuanced than I imagined. Good coaching has many facets and lecturing is not necessarily an effective strategy. Maybe it works temporarily to change behaviour quickly in a risky situation. For the long-term though and to encourage self-momentum, it has diminishing returns.
Lately the power of a single question when problem-solving with others has reminded me of a way to shed the "bossy pants" habit. "What do you think?" is one major personal transformation theme I hear when I follow up with managers who have graduated from our leadership development programs. They don't jump in to provide the answers, as was their habit too often. Although difficult to withhold their opinions, the managers are amazed at the creativity and enthusiasm that follows.
But does such a simple question make a real difference in achieving results? Anson Dorrance is a university soccer coach legend, having led his women's soccer team at the University of North Carolina to 21 national championships over 33 seasons. According to Po Bronson and Ashley Merryman, who have written a fascinating book on the science of winning and losing ("Top Dog), Dorrance learned not to berate or lecture the women after a game played poorly. He simply asked, "What do you think?" The women capably provided the answers.
Fortunately for me my sisters knew that I was just looking out for them. They have both done well. Their playful feedback resonates though. I continue to work on letting go of my "bossy pants" persona to allow the "What do you think?" me to emerge.
Monday, August 05, 2013
Subscribe to: Posts (Atom)


text:
According to a press published by the Alliance for Proton Therapy Access, a trade advocacy group intending to promote the use of Proton Radiation, two presenters provided their findings at the 4th annual Particle Therapy Co-Operative Group – North America (PTCOG-NA) Conference, held October 23rd-25th in Chicago, Ill.
The following is the description, from the press release, of the presented research specific to prostate cancer:
· "William Hartsell, MD from the Northwestern Medicine Chicago Proton Center presented a paper that built on previous research on proton therapy using data from the Medicare and the Surveillance Epidemiology, and End Results (SEER) database. The study found that patients who received proton therapy to treat prostate cancer had a higher likelihood of surviving at five years after treatment (94% versus 87%) with lower risks of bladder complications and a lower chance of being diagnosed with another cancer."
· "Nancy Mendenhall, MD of the University of Florida Proton Therapy Institute (UFPTI) compared results from 1,500 male prostate cancer patients in Florida and Arizona and found that for men who received proton therapy, the likelihood of survival with no evidence of a rise in PSA after five years was 94 percent compared to 87 percent of patients who had been treated with intensity-modulated radiation therapy (IMRT). Patients who had received proton therapy also had a lower risk of side effects in the rectum and bladder than those who received IMRT."
It is remarkable how consistent the data offered was between these two studies. The press release did not provide any statistical analysis of the data so we cannot just assume that the differences are statistically significant, but it does seem as if they probably are significant. Our other concern is that the data is only over a five (5) year period, for prostate cancer this isn't enough time to make any long-term judgments about the overall superiority of proton therapy over IRMT. Prostate cancer needs at least ten (10) years if not fifteen (15) to be considered mature.
Given the significant cost differential between proton therapy and IRMT, not only do we need longer-term information, but we should be looking at a total cost benefit analysis which takes into consideration both the actual cost of the radiation treatment as well as the additional expenses incurred by a man when they have a recurrence.
Joel T. Nowak, MA, MSW wrote this Post. Joel is the CEO/Executive Director of Cancer ABCs. He is a Cancer Thriver diagnosed with five primary cancers - Thyroid, Metastatic Prostate, Renal, Melanoma, and the rare cancer Appendiceal cancer.


text:
FYS students,
Greetings! We hope that your holiday has been rejuvenating. We are excited to introduce your spring First Year Seminar, Mapping American History. The aim of this course is to encourage you to write, research, and analyze sources in increasingly sophisticated ways. As you hone these skills, we will be using primary resources to learn something new about the history of Richmond. We will bring these parts of the class together by thinking about the spaces that Richmonders have created and their connections to places far removed.
We will post more information about how we will use this blog and other online tools in the next couple weeks. In the meantime, we look forward to seeing you Monday, January 10!


text:
3D-model of a pram
Budget $30-100 USD
We need a quick model of a pram created in 3D-studio. We are looking for a good provider that can help us with that and of course further 3D-project that will show up. The pram should look like the attached file.
We need a good modelling in 3D-studio of the image we have attached, no textures or lights is necessary, but a plus.
Note: The project have a small budget, we are expecting bids about $20-$40.
Please send us a PM if You are the one we are looking for!
10 freelancere byder i gennemsnit $54 på dette job
Kindly refer to your PM for details and some clarifications. Thanks!
Hello. I can help you with pleasure take a look on examples of my work at: [login to view URL] If you need, I'll send you more on e-mail My contacts: e-mail: ICQ 246893598 Regards,Andrew.
Hi, i'm interesting for the "small" project, but it seems need building huge detail for this pram, it may take a lot time. plz see pm to view my ability. thx
Its just piece of cake for me. highlly appreciate if given chance.
please contact me at . visit our website:www.aarchitect.com.vn.
It is a easy job for me. I can provide you with high quality.


text:
Phone: 727-446-5721 Fax: 727-443-2479
Contact Us
Website Designed
Make a Website
List Your Business
Property Insurance
provides protection against risks to property, such as fire, theft, or weather damage.
Available Lines of Coverage:
Liability Insurance
is a very broad superset that covers legal claims against the insured. Many types of insurance include an aspect of liability coverage. For example, a homeowner's insurance policy will normally include liability coverage which protects the insured in the event of a claim brought by someone who slips and falls on the property; automobile insurance also includes an aspect of liability insurance that indemnifies against the harm that a crashing car can cause to others' lives, health, or property. The protection offered by a liability insurance policy is two fold: a legal defense in the event of a lawsuit commenced against the policyholder and indemnification (payment on behalf of the insured) with respect to a settlement or court verdict. Liability policies typically cover only the negligence of the insured, and will not apply to results of willful or intentional acts by the insured.
Windstorm Insurance
is an insurance covering the damage that can be caused by hurricanes and tropical cyclones.
Typically, an umbrella policy is pure liability coverage over and above the coverage afforded by the regular policy, and is sold in increments of one million dollars. The term "umbrella" is used because it covers liability claims from all policies underneath it, such as autos and homeowners policies. For example, if you have an auto insurance policy with liability limits of $500,000 and a Homeowners policy with a limit of $300,000, then with a million dollar umbrella, your limits become in effect, $1,500,000 on the auto policy and $1,300,000 on a homeowners liability claim. Umbrella policies are mainly used by those who have sizable unencumbered assets, such as a home with a large amount of equity to ensure that even a catastrophic claim will not allow those assets to be placed at risk.
Boiler Insurance
(also known as boiler and machinery insurance or equipment breakdown insurance) insures against accidental physical damage to equipment or machinery.
Fidelity Bond
is a form of casualty insurance that covers policyholders for losses that they incur as a result of fraudulent acts by specified individuals. It usually insures a business for losses caused by the dishonest acts of its employees.
Flood Insurance
protects against property loss due to flooding. Flooding is defined by the National Flood Insurance Program as a general and temporary condition of partial or complete inundation of two or more acres of normally dry land area or two or more properties (at least one of which is your property) from: overflow of inland waters, unusual and rapid accumulation or runoff of surface waters from ANY SOURCE, and mudflows. This can be brought on by landslides, a hurricane, earthquakes, or other natural disasters that influence flooding.
Workers' Compensation Insurance
replaces all or part of a worker's lost wages and accompanying medical expenses incurred because of a job-related injury.
Directors and Officers Insurance
protects an organization (usually a corporation) from costs associated with litigation resulting from mistakes made by directors and officers for which they are liable. In the industry, it is usually called "D&O" for short.
Automobile Insurance
is probably the most common form of insurance and may cover both legal liability claims against the driver and loss of or damage to the
insured's vehicle itself.
Difference in Conditions
DIC Insurance
provides coverage designed to close specific gaps in standard insurance policies and is usually available only for larger industrial or commercial risks. lt allows coverage to be customized to extend to such exposures as water damage, flood, collapse, earthquake, landslide, etc., according to the insured's needs. DIC coverage may be provided by means of a separate insurance policy or it may be added by endorsement to the basic policy.
Please allow us the opportunity to design an Insurance Package that is right for you!
The extensive use of plate glass in modern architecture has produced a special comprehensive insurance that covers not only plate glass but glass signs, motion-picture screens, halftone screens and lenses, glass bricks, glass doors, and so forth. lt may be Written to cover loss from any source except fire or nuclear radiation. Glass policies provide invaluable coverage while avoiding high hurricane deductibles.
Coverage for bodily injury, property damage or destruction, for which the insured garage and/or its representatives become legally liable resulting from the operation of the garage. This type of policy is also used for Valet.


text:
Chichester - Tower Golf ClubInto the Rough > Golf Courses > West Sussex
Not yet rated. Add a review
Golf Course Details:
Yardage: 6109
Number Of Holes: 18
Par: 71
Club Pro: J Willmott
Green Fees: Tower: £16.00 (£22.00 wknd). Cathedral: £20.00
Club Shop: Yes
Tee off times: Find available tee times
View more golf courses in West Sussex
Address & Contact Details:
Main Contact: email@example.com
Address: Hunston Village, Chichester, West Sussex, PO20 6AX
Map: View directions for Chichester - Tower Golf Club
Telephone: 01243 528999
Link: http://www.chichestergolf.com
Hotels close to Chichester - Tower Golf Club:
Alexander House and Utopia Spa - Turners HillFrom £99
East Street, Turners Hill, Nr Gatwick RH10 4QD
Millstream Hotel and Restaurant - ChichesterFrom £72
Bosham Lane, Bosham, Chichester, West Sussex PO18 8HL
Angmering Manor - WorthingFrom £79
High Street, Angmering, West Sussex BN16 4AG
The George Hotel - BramberFrom £54
High Street, West Sussex, Henfield BN5 9DB
White Horse Inn - PulboroughFrom £65
2 The Square, Storrington, W.Sussex RH20 4DJ


text:
Beth, of BlueValentinePress.Etsy.com submitted this book for our book swap. It features a unique mini collage on the front cover. The collage includes a gocco print, some reclaimed text and other torn papers that have holes made using a Japanese hole punch. The lovely pocket-sized book is bound with an exposed chain stitch sewing.
Visit BlueValentinePress's Etsy shop to see more of her work.
See all the books from Book Swap #2
Monday, 31 March 2008
Book Swap #2 - BlueValentinePress
Posted by MyHandboundBooks at 21:35
4 comments:
- lapaperie&cozy said...
That's lovely. :)
- 31 March 2008 at 21:41
- meredeth said...
hey hey! i got that book! and i've already used it, too. what kind of paper is that, by the way? because it rocks.
- 31 March 2008 at 22:57
- Blue Valentine Press said...
I'm glad you like it and are using it! I think you mean the inside pages paper and that's Mohawk Super Fine Smooth -it does rock, takes ink, pencil, and glue like a champ!
- 1 April 2008 at 09:23
- Lady Artisan said...
This is beautiful! I love collage pieces and earth tones--great combination.
- 6 April 2008 at 09:05
Subscribe to: Post Comments (Atom)


text:
Everybody Wonders About Future as Half of Big 12 on Off Week
DALLAS (AP) -- With half the Big 12 heading into an off week, there are more questions about the league's future. Oklahoma coach Bob Stoops and Texas' Mack Brown insists their focus is on what's happening on the field. Of course, they both know their teams will be fine no matter what happens.
Kansas coach Turner Gill said Monday on the coaches' conference call that he's got faith that the Big 12 "will be standing strong at some point in time," even if nobody knows how it will shake out.
Oklahoma's president has said the Sooners will decide soon if they will go to another conference or stick with the Big 12. Texas A&M has already said it's leaving.


text:
"At least you have your health..."
Wednesday, February 27, 2008 by ShawnieMac
We've all heard the adage, right? It's sort of silly, when you think about it though. Is the thinking that if you're healthy, you can probably face anything? And truly, what on earth does this mean?
I find that now that I've put the restraining order on all things cancer and chemo, I seem to have less to write about. While it may seem like this renewed health has sapped my creativity, I think my lack of interesting things to say is really more of a lack of things to bitch about. Not that I bitched much anyhow... I suppose it depends on who you ask and on which day.
I find that now that I've put the restraining order on all things cancer and chemo, I seem to have less to write about. While it may seem like this renewed health has sapped my creativity, I think my lack of interesting things to say is really more of a lack of things to bitch about. Not that I bitched much anyhow... I suppose it depends on who you ask and on which day.
Today I decided to see if I was ready for mascara. After pushing my face as close as possible to the mirror and giving my eyelids a couple of half-hearted swipes with the wand, resulting in a couple of clumps of black below my eyes and about half a dozen eyelashes that miraculously appeared, I resigned myself to the fact that it just wasn't time yet. Out came the q-tip to rescue my few and humble eyelashes from unnecessary goop. Perhaps next week.
I did, however, thankfully decide that it was time to shave my armpits. Spot on, with that decision.
I have a couple of very close friends who are going through some challenging times right now. One was recently betrayed by someone she decided to trust and let into her life. Another is struggling with trying desperately to find the balance of her own happiness in juxtaposition with that of her family's while struggling with the chance that these two could be polar opposites. Yet another, after the trials and tribulation of in-vitro and a difficult pregnancy carrying triplets, recently gave birth, extremely prematurely. She lost one of her babies, and the other two tiny lives continue to fight. How does one say "congratulations" and "I'm so sorry" at the same time? It's so difficult to know that people you love are hurting, and in the big picture, there's not a damn thing you can do other than let them know you care. Sometimes it just doesn't seem like enough.
The irony of it all is that I made the comment, "Me? I've got it easy with this cancer stuff." It certainly feels that way sometimes.
It was a beautiful morning - warm enough to hike comfortably yet cool enough to enjoy the bite of the morning air. It was the first morning that sunrise finally came before 7:00 am (OK, so it was 6:59 exactly) and the first weekday morning as long as I can remember that we ventured up Telegraph Pass. It was a strangely quiet morning on the trail and we didn't see another soul on the entire hike down. The morning gave me yet another chance to take a minute to reflect on how fortunate I truly am these days. Sure, I have another PET coming up in March. And the truth is, I'm scared to death. I don't want this respite to end, and I know I'll take it hard if it has to. Then again, that's all the air time I'm going to give it until the scan is scheduled and I'm waiting for results. At least, that's my plan.
In the meanwhile? I'm going to enjoy the weather as much as I can as it's currently the type of weather people move out here for. I'm going to look forward to seeing the wildflowers for the first time on our Superstition Mountains hike this weekend.
I'm going to continue to be thankful in ways I can't express for finding the right love at the right time. That in and of itself is no small feat.
And right now? At least I have my health...


text:
Blindspot Returns Friday, October 12
|Season 4 Premiere –The team learns that Jane is slowly dying from being poisoned, but they don't know Remi is back; one of the symptoms of the poisoning — hallucinations — has her seeing Roman, who indulges Remi's darkest desires.
|When Jane Doe is found naked in Times Square with her memory erased and her body covered in fresh tattoos, Agent Kurt Weller and his FBI team are instantly drawn to the case. Together, they discover each tattoo is a clue, making Jane's body a maze of mysteries that must be solved to uncover her true identity. But as Jane and Weller get closer to unveiling her past and discovering who set this riddle in motion, they find the quandary goes deeper than they ever imagined, involving people they thought they could trust.
Get more information on 'Blindspot' on NBC.


text:
Yoga Shack BC is super excited to offer three workshops with three teachers this Fall, every second Saturday morning, starts November 7th.
Every other Saturday you can enjoy a morning of exploring new ways to move in your body, recalibrate innate patterns, transforming both body and mind while you soothe and calm the nervous system and balance into renewal.
Each workshop is presented on a Saturday morning from 10am – 12.30pm. You can Register Online Here.
November 7th we present Servaas Mes in: Grounding in 'I am'.
Join us for an embryological experiential journey to help recalibrate your innate movement patterns. In this class we are pioneering new routines that connect us to our embryological Self, connect us to our earlier days outside the womb, and explore other movements that bring us into the present moment as adults. When you re-connect with your authentic somatic movement patterns we begin our lives with, your possibilities become infinite!
December 5th Yoga Shack's owner Rosie Williams offers: Relax into Renewal
Sometimes you need to step back to move forward. Enjoy a morning to help you ground in contemplative practices to calm the mind, rejuvenate the body and awaken insight and inspiration. We will practice restorative yoga poses which will help to deeply relax the body, soothe and calm the nervous system, and boost the immune system.
Discover relaxation and wakefulness in our pristine mountain environment as you explore through breath a session of restorative poses, mindful movement and relaxation tools to take home with you into everyday life.
Rosie Williams
Is the owner of Yoga Shack BC and is very excited to offer this Fall Workshop Series completing it with a session to fully renew and refresh before the Christmas rush. Rosie is a 200hr Yoga Alliance certified teacher with a 650hr Yoga & Pilates Academy teacher training in 2003. She has a tonne of passion of her love of yoga to share you.
I would LOVE to register for the Fall Workshop Series. Register Here!


text:
The Old Man & the Gun
Edwin Arnaudin: I'm starting to doubt that David Lowery and I will ever get on the same cinematic wavelength. The prolific filmmaker has made four features in the last five years, and while there's a lot to admire technically and sometimes dramatically and narratively about Ain't Them Bodies Saints, Pete's Dragon, A Ghost Story, and now The Old Man & the Gun, each one has left me feeling like a grand opportunity was missed. What's your experience with his oeuvre?
Bruce Steele: I haven't seen Bodies, perhaps his best-reviewed film, but the contrasts between his other films suggest a highly adaptable filmmaker. Dare I say, a director for hire? Pete's Dragon was an attempt to launch a Disney franchise, while A Ghost Story was a zero-budget personal essay. Now The Old Man & the Gun, produced by its star, Robert Redford, takes a true story and strips it down to what I can only imagine are Redford's chief interests. I'm guessing his interests didn't much interest you.
Edwin: I was more than willing to take this pseudo Redford retrospective and got frequent delight from watching his charming bank robber Forrest Tucker, at least until Lowery gets in the way.
Bruce: It's definitely a Redford retrospective, including countless photos of younger Bob (I mean, Forrest) and even clips from The Chase, Redford's 1966 prison escape yarn. Were you not intrigued?
Edwin: Initially, sure. I've been interested in the writer/director's subject matter from film to film — other than a knee-jerk "The hell do we need a new Pete's Dragon?" reaction — and the same is true here. It's his execution, however, that leaves me wanting — one of appealing players, scenarios, and scenes, bogged down by a lack of character development but also stretches that unimaginatively attempt to sketch in his leads. I left feeling like I knew nothing about anyone besides Tucker, but maybe that was the point?
Bruce: I doubt Lowery intended to leave us in the dark about Jewel (Sissy Spacek), the widow with a horse farm Tucker woos, or John Hunt (Casey Affleck), the local cop who pursues him, or even Tucker's sometimes accomplices, Teddy (Danny Glover) and Waller (Tom Waits). But since none of these people bears much resemblance to the actual people on which they were based, it was up to Lowery (as the screenwriter) to fill in the absent facts with rich fabrications. Keeping everyone shadowy keeps the focus not on Tucker but on Redford, who's essentially playing himself: the elderly guy who's still in great shape, loves his job and can't seem to quit. Maybe he heard that Tucker's crew was dubbed the Over the Hill Gang and thought it was a good coda for the Sundance Kid.
Edwin: Or he was pissed off at not getting an Oscar nomination for the dreadful All Is Lost — of which I know you're a fan — and was able to wear down his Pete's director into giving him a…less boring vehicle to achieve those ends. And I think he's good here, and as warm and gentlemanly to viewers as he is to the numerous bank managers and tellers he nonviolently convinces to hand over suitcase after suitcase of cash. If he wasn't, The Old Man & the Gun would be akin to a feature-length version of Rooney Mara's pie-eating scene from A Ghost Story, and nobody wants to see that.
Bruce: I didn't want to see it the first time around. The Old Man & the Gun isn't much of an Oscar vehicle, though. It's not quite a whimper, but it's not a bang. It's just a slow, graceful exit — a tip of the hat, as depicted on the poster, that will make fans smile but without tears of the happy or the sad variety. That's why I was fascinated to read the original New Yorker article that inspired the film and learn how all the grit of Tucker's life had been sanded away. If Redford wanted a grand finale, Lowery could have given him a nasty side, or a tortured soul, beneath the jovial surface. Or do you think that kind of complexity is beyond the writer-director's skill set?
Edwin: Easy as it is to rag on A Ghost Story, once its structure and ultimate purpose become clear, it produces a mature, soulful cumulative effect. Getting to that point is where Lowery frequently loses me, and it's the same here just about any time Tucker has an extended conversation. It's in the action of his films where I think Lowery is most impactful and gets across perhaps more character development and emotions that he realizes. Then he goes and hampers his progress with extraneous chitchat. Like many of today's filmmakers in their 20s and 30s (Lowery turns 38 on Boxing Day), maybe he needs some behind-the-scenes collaborators to help hone his gifts.
Bruce: It's the rare filmmaker who cannot benefit from collaboration, and I agree that The Old Man & the Gun could have benefited from input by someone who wasn't Redford or Lowery. I wasn't as put off by the conversations as you were — the first Redford-Spacek meeting is nice, they have one or two more nice talks, and Waits has perhaps the best mini monologue in a scene with Redford and Glover. The Waits bit, though, highights the general lack of self-reflection by the main characters, including Affleck's unhappy copper. This is a good cast, and they all fit their roles nicely, so it didn't strike me as a grievous fault so much as a missed opportunity. I still think fans of the cast will be happy they saw the movie.
Edwin: If it sounds like I hated the movie, I didn't. The heists (mild though they may be) are exciting, moments like the montage of Tucker's numerous prison escapes show how good Lowery can be when he's not writing dialogue, and the desire to see our guy remain a few steps in front of the law is generally enough to sustain viewer interest. I just wish it added up to more than, "OK, that was fine," and a corresponding B-minus grade.
Bruce: I found it a hair better than fine, but was hoping for warm and wonderful. I did like the heists and escapes you highlight, and the pairing of Redford and Spacek is pleasing. There are a few fine comic chases that stand out as well, underscoring your point about the director's action skills. It doesn't add up to the career capper we might have hoped for, but I'll give it a solid B.
Grade: B. Rated PG-13. Now playing at Carolina Cinemark and the Fine Arts Theatre
(Photos: Fox Searchlight)


text:
O'Brien Luxury Homes, LLC 515 E Carefree Highway, No-81 Phoenix, AZ 85085 623-869-7160 firstname.lastname@example.com ROC# 286797
O'Brien Luxury Homes, LLC 515 E Carefree Highway, No-81 Phoenix, AZ 85085 623-869-7160 firstname.lastname@example.com ROC# 286797
DESIGNED: Patrick O'Brien
ARCHITECTURAL STYLE: Italian Farmhouse
SERVICES PROVIDED: Complete architectural blueprints, all interior design, colorization, material specifications, landscaping design, new custom build
Welcome to Casa di Pietra, a home built of stone, antique wood beams and intricate details. What started as a vision of an Italian stone farmhouse has been transformed into a reality infused with Old World ambiance and distinct artistry. This home consists of Master suite, 2 additional suites / 4 ½ baths, casita with full bath, great room, large gourmet kitchen, library, formal dining, home theater, media room, billiard room, wine cellar, walk-in cigar humidor, 8 masonry fireplaces, 2 wet bars, multiple outdoor living spaces.
A bright circular Entrance Foyer with historically correct wall coverings enhance the portal to the home and portray the authenticity and craftsmanship of the era. The Living Room/Family Room is nearly 1,000 sq.ft with a massive fireplace created from one piece of stone weighing almost 16 tons.
The Master Suite has a separate sitting area with a floor-to- ceiling, two-sided fireplace and a mini kitchenette with refrigerator, sink and microwave. French doors provide easy access to the main veranda and spa. The Master Suite Bathroom scene emerges around the centered 6-ft diameter whirlpool tub and the 3-sided peninsula fireplace, which radiates unmatched ambiance throughout.
Casa di Pietra is prepared with a Crestron home automation system allowing control of all media and music functions, HVAC, lighting, network wiring and security throughout the home. The home is equipped with Wi-Fi technology, an Aqualink electronic system for the pool and spa, and an automated igniting system for all eight fireplaces. A total of five heating/cooling furnaces with 13 seer condenser units, four hot water heaters, a three-stage r/o system and 600 amp electrical service provide comfort and convenience throughout.
It's rare to find a home whose exterior matches the grandeur of the interior, but at Casa di Pietra, the 2,400 sq.ft. of covered patio areas breaks new ground. Complementing this outdoor scene is a tranquil negative edge pool with a stone water feature and an expansive tiled spa, perched above the landscape below. With amenities such as a 52" stainless steel BBQ grill and sink, refrigerator and a 3-sided custom stone fireplace, your al fresco moments are elevated to another level.


text:
I am a naturalist painter with over 26 years experience working with acrylics on canvas. I admire the Lord's divine creation, thus, my body of work consists mostly of landscapes (local beaches and coastal towns), nature (all sorts of local fauna and marine life), as well as my culture.
During cruise days, my prints are exhibited at the Tabyana Beach gift shop; on weekends or when there are no cruise ships, you can find my work also at Tabyana but closer to West Bay beach. I also have a stand at the Cruise Port at Mahogany Bay. My Sales Agent is Tristan Monterroso.
If you are interested in purchasing my work but cannot take it with you because of its size, I can fold it for you and I can make sure it is delivered to your address wherever you live. I also do personalized work - send me the photograph of your choice and I can have it painted in any size you want and according to your specifications.


text:
Five gold Transform awards for Living in NY 27 October 2016
Last night saw the second Transform North America Awards in New York, where we had eleven nominations for our brand work with clients Ashurst, CFM, Givergy and Orrick.
The evening saw us pick up three gold awards for technology specialists Givergy and one each for law firm Ashurst and hedge fund CFM respectively. Law firm Orrick also picked up two silver awards.
The awards consistently set a stronger benchmark for work in brand development while reflecting the growing significance of brand in strategic corporate communications. The corporate brand – and its implementation, positioning and creativity – has become one of the most valuable assets a business owns. A full list of the winners can be found here.
One of the judges said "It was great to see everything from schools to packaging manufacturers and household names and it was an honour to judge this second year of Transform Awards in North America, as it gave me the opportunity to read some amazing work and was truly impressed by the quality and diversity of the projects. The winners should be proud, as their submissions represent some of the most innovative brand strategy and creative work in the industry."
For more information on our award-winning brand work, please contact Greg Hobden in London, Aliena Lai in Hong Kong, or Kate Shaw in New York.


text:
Essential Details You Can Learn From A Pick Up Artist.
For those who don't know who are the pickup artists, they are mostly those upcoming or established artist that are able to appeal and attract a girl after they
have done something and they have a way of winning a girls liking in the simplest and superb way possible. This article will enlighten you on how the pickup artists are able to date and get a girl after some deals in the bar and you will learn more about their dating lifestyles.
First, pick up artists are very courageous and full of confidence and they would enter a place with more composure and in styled walking that will reveal to everyone that they are around or they have arrived and this helps them to gather internal confidence that oozes in them to do anything they come across. Moreover, these pick up artists are usually very clean, neat, presentable and full of organizations and this comes with the way they cloth and their talking itself can prove that and this means any physical appearance is vital to them attracting women that are known to like artistic neat clothing and presentations.
For many, humor is life due to laughter and women are more considerate when they encounter an artist with enshrined sense of humor and they may even force a conversation that will later yield a long lasting friendship and eventually marriage. The picks up artists are noticed when they chat or converse with women that stimulate humor and laughter leading to being liked.
For proper and efficient of winning women on their side, the pickup artists exhibit politeness to women as they are aware that girls like polite guys and would do all that it takes to have such. If you want to win that woman, you must have a cute mastery of flirting details and this should involve mouth exquisite tones accompanied by rhythmic genuine body language that will truly show you are interested and the woman will definitely be yours.
Becoming a pick up artist requires such features which you can practice and be a pro in winning women at bars due to your physical exhibitions. Again, it's vital to remain the real you and not faking anything as women are wise and not stupid and they will let you down when you try to pretend or exhibit some funny comic features which can make you mission to fail.
Getting a girl on your side is not a tasting idea and the confidence and self esteems are the guiding factor so you need to keep chatting and conversing with women often to gain experience.


text:
News & Announcements
Quick Links
Exterior Hazard Abatement RequirementsPosted: 10-Jul-2018
Each year in mid-April the Fire District sends out over 13,000 postcards advising property owners of the June 15th deadline to abate their properties to be in compliance with the Moraga-Orinda Fire District's Exterior Hazard Control Standards.
All District property owners have a shared responsibility to provide a fire safe environment and maintain their property free of exterior fire hazards throughout the fire season. Abundant rainfall has led to excessive growth of plants and grasses this year. The annual growth of grasses can change from beautiful green to a very flammable brown in just a few weeks.
The opportunity to get the work done after the rain has stopped and before the fire season starts can be a very narrow window. Planning to get this work done sooner will reduce wildfire risk. Each year the State of California experiences a number of significant large fires in early June which reinforces the need to have our vegetation management done early in the season.
Property owners can also schedule a free FireWise assessment, which the District offers as a customized tool to reduce risk on individual parcels. To schedule a FireWise assessment, please call 925-258-4525, Ext. 524.
It is not the District's intent to insinuate that property owners are currently in violation of the law. Violation only occurs if the specified work is not completed prior to the compliance date of June 15th.
Inspections of properties will start the week following the compliance date of June 15th. If properties are inspected and found to be non-compliant, our staff will follow a legal process of notices, which can result in the District contracting to have the work done and a lien placed on the property to recover our costs.
If you have any questions or concerns regarding a property, please feel free to contact the MOFD Fire Prevention Division at (925) 258-4525 ext. 524. Complaints will be taken after the June 15th compliance date and we will inspect properties for compliance and follow-up with the owners.
The Moraga-Orinda Fire District is thankful to all of the citizens who make fire safety a priority. Together, we can share the responsibility in making our communities fire safe.
Kathy Leonard
Fire Marshal